Voloridge Investment Management
RNAM

Voloridge Investment Management’s Avidity Biosciences RNAM Stock Holding History

Voloridge Investment Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-642,224
Closed -$46.3M – 1236
2025
Q4 		$46.3M Buy
+642,224
New +$41.5M 0.16% 158
2025
Q1 		– Sell
-191,550
Closed -$5.57M – 1343
2024
Q4 		$5.57M Buy
191,550
+134,489
+236% +$5.62M 0.02% 747
2024
Q3 		$2.62M Sell
57,061
-74,980
-57% -$3.25M 0.01% 902
2024
Q2 		$5.39M Buy
+132,041
New +$3.79M 0.02% 729
2021
Q2 		– Sell
-18,527
Closed -$404K – 1753
2021
Q1 		$404K Buy
+18,527
New +$454K ﹤0.01% 1218

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Voloridge Investment Management's RNAM Position: Q1 2026 in Review

Voloridge Investment Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 642,224 shares — an estimated $46.3M sold.

Voloridge Investment Management first reported a position in RNAM in Q1 2021 and held it in 5 quarters. The position peaked at $46.3M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Voloridge Investment Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 642,224 Avidity Biosciences shares in Q1 2026, an estimated $46.3M.
  • Voloridge Investment Management first reported a position in Avidity Biosciences in Q1 2021 and held it in 5 quarters.
  • Voloridge Investment Management's Avidity Biosciences position peaked at $46.3M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Voloridge Investment Management's 13F filing for Q1 2026, filed 15 May 2026.